Global /China /Healthcare /Drug Manufacturers - General /002688

Jinhe Biotechnology CO., LTD.

002688

• SHE: 002688 • Delayed

6.02CNY 0%

0.8896 USD

As of 14 June 2026, Jinhe Biotechnology CO., LTD. has a market cap of $666.31M USD, ranking #13241 globally and #4000 in China. It ranks #1200 in the Healthcare sector, and #444 in the Drug Manufacturers - General industry.

Global Rank

13241

Country Rank

4000

Sector Rank

1200

Industry Rank

444

Key Stats

Market Cap

$666.31MUSD

4.51B CNY

Enterprise Value

$950.17MUSD

6.43B CNY

Revenue (TTM)

$424.75MUSD

2.88B CNY

EBITDA (TTM)

$83.92MUSD

567.89M CNY

Net Income (TTM)

$4.07MUSD

27.56M CNY

EBITDA Margin

20%

Profit Margin

PE Ratio

170.5

Forward PE

20.1

PS Ratio

1.6

PB Ratio

1.8

EV/EBITDA

11.1

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Changxian Xie open_in_new

Employees

2,476

Founded

1990

Website

jinhe.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	4.9%	2%	-10%	-11%	1.2%	-3.7%	20%	-5.6%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	002688 金河生物科技股份有限公司 Class A ISIN: CNE100001HK7 Shares Out.: Shares Outstanding: 755.683M¹ Shares Float: 460.714M² TV: TradingView: SZSE: 002688 SA: Stock Analysis: SHE: 002688 YF: Yahoo Finance: 002688.SZ GF: Google Finance: SHE: 002688 BA: Barron's: 002688 MS: Morningstar: XSHE: 002688	6.02 CNY	TV: TradingView: SZSE: 002688 SA: Stock Analysis: SHE: 002688 YF: Yahoo Finance: 002688.SZ GF: Google Finance: SHE: 002688 BA: Barron's: 002688 MS: Morningstar: XSHE: 002688

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Jinhe Biotechnology CO., LTD.

Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China and internationally. It offers chlortetracycline premixes; veterinary drug and powder series; disinfectants; and sprinklers. It also engages in the production and sales of feed and raw materials. The company was founded in 1990 and is headquartered in Hohhot, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 8K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 7K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 4K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 3K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 2K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 2K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 114K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 82K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 54K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 48K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 43K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 41K%	20.5	Switzerland

chevron_leftBack